| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 09/09/2009 | CN101524412A Traditional Chinese medicine composition for treating kidney failure and preparation method thereof |
| 09/09/2009 | CN101524384A Preparation process for manyprickle acathopanax root extract |
| 09/09/2009 | CN101524362A Application of nucleic acid with CpG motif for preparing anti-fibrotic drug |
| 09/09/2009 | CN101524356A Use of dopamine D3 receptor ligands for production of drugs for treating renal function disorders |
| 09/09/2009 | CN101524337A Prolonged release mucosal bioadhesive system |
| 09/09/2009 | CN101524190A Disease preventing and curing medicinal mouth-muffle and medicinal composite |
| 09/09/2009 | CN100537573C Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group |
| 09/09/2009 | CN100537571C Imidazo[1,2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/09/2009 | CN100537546C Novel alkansulfonamides as endothelin antagonists |
| 09/09/2009 | CN100537520C N-bridged selective androgen receptor modulators and methods of use thereof |
| 09/09/2009 | CN100536922C Polymeric delivery formulations of leuprolide with improved efficacy |
| 09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
| 09/08/2009 | US7585888 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
| 09/08/2009 | US7585507 Nucleic acid molecules and polypeptides for immune modulation |
| 09/08/2009 | CA2360360C Piperidyl benzamide compounds, composition containing same and their use thereof |
| 09/08/2009 | CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/03/2009 | WO2009108383A2 Substituted xanthine derivatives |
| 09/03/2009 | WO2009108375A1 Substituted xanthine derivatives |
| 09/03/2009 | WO2009106708A2 Azetidine derivatives, their preparation and their application in therapy |
| 09/03/2009 | US20090221821 Adenosine receptor antagonists and methods of making and using the same |
| 09/03/2009 | US20090221650 Use of Pyridoxamine to Treat and/or Prevent Disease Processes |
| 09/03/2009 | US20090221632 Bicyclo-Pyrazoles and Pharmaceutical Compositions Comprising Them |
| 09/03/2009 | US20090221602 Processes for preparing substituted pyrimidines |
| 09/03/2009 | US20090221589 Use of aminoalcohol derivatives for the treatment of overactive bladder |
| 09/03/2009 | US20090221543 New corticosteroids |
| 09/03/2009 | US20090220568 Methods for treating a stricture with a botulinum toxin |
| 09/03/2009 | US20090220493 Reagents and methods for inducing an immune response to prostate specific antigen |
| 09/03/2009 | DE19521720B4 Insulinanalogonformulierungen Insulin analog formulations |
| 09/03/2009 | CA2716788A1 Substituted xanthine derivatives |
| 09/03/2009 | CA2709863A1 Azetidine derivatives, their preparation and their application in therapy |
| 09/02/2009 | EP2094704A2 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 09/02/2009 | EP2094289A1 Conjoint therapy for treating fibrotic diseases |
| 09/02/2009 | EP2094258A1 Pharmaceutical composition using aliskiren and avosentan |
| 09/02/2009 | EP1696932B1 Use of treprostinil to improve kidney functions |
| 09/02/2009 | EP1496890B1 Substituted beta-aminoalcohols used as medicaments |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | EP1466925B1 Antibodies against fibroblast growth factor 23 |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1317479B1 Methods and compositions for diseases associated with amyloidosis |
| 09/02/2009 | EP1087991B1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 09/02/2009 | CN101519427A Peptide derivative with endothelin receptor antagonizing activity, drug composition and application thereof |
| 09/02/2009 | CN101519386A Large conductance calcium-activated K channel opener |
| 09/02/2009 | CN101518650A Combination of a DPP IV inhibitor and a cardiovascular compound |
| 09/02/2009 | CN101518648A Soluble receptor BR43x2 and methods of using |
| 09/02/2009 | CN101518645A Application of marine collagen peptide in preparing drugs, health care food or food for protecting renal function and delaying the process of chronic renal failure |
| 09/02/2009 | CN101518634A Traditional Chinese medicine for treating prostatic hyperplasia |
| 09/02/2009 | CN101518625A Drug for treating toxuria |
| 09/02/2009 | CN101518623A Traditional Chinese medical composition for treating chronic nephritis and preparation method thereof |
| 09/02/2009 | CN101518622A Traditional Chinese medicine for treating diabetes complicated with urinary infection |
| 09/02/2009 | CN101518607A Traditional Chinese medicine for treating carcinoma of kidney |
| 09/02/2009 | CN101518584A Traditional Chinese medicine for curing urinary system infection and preparation method thereof |
| 09/02/2009 | CN101518553A Oral medicinal preparation of ginkgo leaf total flavonoid aglycone, preparation method and an application thereof |
| 09/02/2009 | CN101518334A Spleen-strengthening, kidney-tonifying and blood sugar reducing cake |
| 09/02/2009 | CN100534997C C-aryl glucoside SGLT2 inhibitors and method |
| 09/02/2009 | CN100534988C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 09/01/2009 | US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling |
| 09/01/2009 | US7582657 Vanilloid receptor ligands and their use in treatments |
| 09/01/2009 | US7582651 Pyrrolopyridine derivative and use thereof |
| 09/01/2009 | US7582647 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582640 3-[[5-Ethyl-6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine; osteoporois; restenosis; arteriosclerosis; cell adhesion/bone bioresorption inhibiters; cardiovascular disorders; antitumor agents; anticarcinogenic agents; bone disorders |
| 09/01/2009 | US7582635 Benzoazolylpiperazine compounds inhibition of gluatmate receptors; for treatment of urinary incontinence, ulcers, irritable-bowel syndrome, inflammatory-bowel disease, addictive disorders, Parkinson's disease, parkinsonism, anxiety, epilepsy; kits |
| 09/01/2009 | US7582619 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging |
| 09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
| 09/01/2009 | CA2403977C .gamma.-tocotrienol-containing diuretics |
| 08/27/2009 | WO2009104729A1 Amide derivative and pharmaceutical composition containing the same |
| 08/27/2009 | WO2009104248A1 Adrenomedullin production enhancer |
| 08/27/2009 | WO2009103477A1 Compositions for the treatment of benign prostate hypertrophy, prostatitis, prostatosis and prostate cancer |
| 08/27/2009 | WO2009103312A1 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases |
| 08/27/2009 | WO2009082526A3 Ortho pyrrolidine, benzyl-substituted heterocycle ccr1 antagonists for autoimmune diseases & inflammation |
| 08/27/2009 | WO2009053857A3 Management and treatment of benign prostatic hyperplasia |
| 08/27/2009 | US20090215809 crystalline calcium (3S)-{[(1R)-isobutanoyloxyethoxy]carbonylaminomethyl}-5-methyl-hexanoate hydrate; sustained release oral dosage formualtion with opioid agonist, selective serotonin re-uptake inhibitor and noradrenaline re-uptake inhibitor; an inflammatory disease, neuropathic pain, anxiety, psychosis |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215748 FXR agonists for treating vitamin D associated diseases |
| 08/27/2009 | US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 08/27/2009 | US20090214675 4-Chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof |
| 08/27/2009 | US20090214642 Coated formulations for tolterodine |
| 08/27/2009 | US20090214422 DNA encoding a novel RG1 polypeptide |
| 08/27/2009 | CA2716032A1 Compositions for the treatment of benign prostate hypertrophy, prostatitis, prostatosis and prostate cancer |
| 08/27/2009 | CA2715771A1 Adrenomedullin production enhancer |
| 08/27/2009 | CA2713412A1 Amide derivative and pharmaceutical composition containing the same |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |
| 08/26/2009 | EP2091927A1 Thiazole and oxazole-substituted arylamides |
| 08/26/2009 | EP2091546A1 Use of a phytosterol containing composition for the treatment of luts. |
| 08/26/2009 | EP2091542A1 Novel use of inhibitors of soluble epoxide hydrolase |
| 08/26/2009 | EP1506951B9 Method for the preparation of total salvianolic acid |
| 08/26/2009 | EP1496929A4 Use of c5a receptor antagonist in the treatment of fibrosis |
| 08/26/2009 | EP1237915B1 Polynucleotid encoding the rg1 polypeptide |
| 08/26/2009 | CN101513481A Pure Chinese medicinal preparation for treating infantile enuresis, and preparation method thereof |
| 08/26/2009 | CN101513443A Drug for treating inflammation in urinary system and preparation method thereof |
| 08/26/2009 | CN101513396A Method for preparing ciprofloxacin hydrochloride time-release capsule |
| 08/26/2009 | CN100531785C A medicine for treating prostatitis |
| 08/26/2009 | CN100531754C Medicine for treating renal calculus and its preparation process |
| 08/26/2009 | CN100531749C Nephropathy treating medicine composition and its preparation process |
| 08/25/2009 | US7579445 Reagents and methods for inducing an immune response to prostate specific antigen |
| 08/25/2009 | US7579357 Antidiabetic agents; obesity; controlling appetite |
| 08/25/2009 | US7579354 3-[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro- 1H-purin-8-yl)- bicyclo[2.2.2]oct-1-yl]-propionic acid or pharmaceutically acceptable salts; highly potent and selective diuretics; treatment of cardiac and circulatory disorders, degenerative disorders of central nervous system |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | US7579186 Human monoclonal antibody against TGF-β type II receptor and medicinal use thereof |